BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 8013162)

  • 21. Relationship between water compartments, body composition assessed by bioelectrical impedance analysis and blood pressure in school children.
    Łątka M; Wójtowicz K; Drożdż T; Dąbrowska E; Kwinta P; Pietrzyk JA; Drożdż D
    Przegl Lek; 2016; 73(1):1-5. PubMed ID: 27120940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles and clinical application of assessing alterations in renal elimination pathways.
    Tett SE; Kirkpatrick CM; Gross AS; McLachlan AJ
    Clin Pharmacokinet; 2003; 42(14):1193-211. PubMed ID: 14606929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in lean body mass and total body weight are weakly associated with physical functioning in patients with HIV infection.
    Wilson IB; Jacobson DL; Roubenoff R; Spiegelman D; Knox TA; Gorbach SL
    HIV Med; 2002 Oct; 3(4):263-70. PubMed ID: 12444944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass.
    Salazar DE; Corcoran GB
    Am J Med; 1988 Jun; 84(6):1053-60. PubMed ID: 3376975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new TOBEC instrument and procedure for the assessment of body composition: use of Fourier coefficients to predict lean body mass and total body water.
    Van Loan M; Mayclin P
    Am J Clin Nutr; 1987 Jan; 45(1):131-7. PubMed ID: 3799498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic basis of using body size and maturation to predict clearance in humans.
    Anderson BJ; Holford NH
    Drug Metab Pharmacokinet; 2009; 24(1):25-36. PubMed ID: 19252334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in pharmacokinetics in elderly patients].
    Nadai M; Katoh M
    Nihon Rinsho; 2013 Jun; 71(6):999-1003. PubMed ID: 23855202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propofol clearance in morbidly obese children and adolescents: influence of age and body size.
    Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
    Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
    Pai MP
    Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of obesity on drug disposition.
    Blouin RA; Kolpek JH; Mann HJ
    Clin Pharm; 1987 Sep; 6(9):706-14. PubMed ID: 3315402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
    Kendrick JG; Carr RR; Ensom MH
    Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can lean body mass be used to reduce the dose of heparin and protamine for obese patients undergoing cardiopulmonary bypass?
    Baker MS; Skoyles JR; Shajar FM; Skinner H; Richens D; Mitchell IM
    J Extra Corpor Technol; 2005 Jun; 37(2):153-6. PubMed ID: 16117451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical treatment guide for dose individualisation in cancer chemotherapy.
    Canal P; Chatelut E; Guichard S
    Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity.
    Bretagne M; Jouinot A; Durand JP; Huillard O; Boudou Rouquette P; Tlemsani C; Arrondeau J; Sarfati G; Goldwasser F; Alexandre J
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):45-53. PubMed ID: 28508095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic variability in the adolescent: implications of body size and organ function for dosage regimen design.
    Rodman JH
    J Adolesc Health; 1994 Dec; 15(8):654-62. PubMed ID: 7696286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nutritional assessment.
    Harrison JE; McNeill KG
    Blood Purif; 1994; 12(1):68-72. PubMed ID: 7986479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism-based concepts of size and maturity in pharmacokinetics.
    Anderson BJ; Holford NH
    Annu Rev Pharmacol Toxicol; 2008; 48():303-32. PubMed ID: 17914927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Existing equations to estimate lean body mass are not accurate in the critically ill: Results of a multicenter observational study.
    Moisey LL; Mourtzakis M; Kozar RA; Compher C; Heyland DK
    Clin Nutr; 2017 Dec; 36(6):1701-1706. PubMed ID: 27697303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of creatinine excretion in body-composition studies of healthy men and women older than 60 y.
    Welle S; Thornton C; Totterman S; Forbes G
    Am J Clin Nutr; 1996 Feb; 63(2):151-6. PubMed ID: 8561053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.